| Dr Van B Ly, OD | |
|
319 7th Ave Se, Suite #101, Olympia, WA 98501-1325 | |
| (360) 357-2544 | |
| (360) 786-8734 |
| Full Name | Dr Van B Ly |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 17 Years |
| Location | 319 7th Ave Se, Olympia, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386836591 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3211ATI (Oregon) | Secondary |
| 152W00000X | Optometrist | 60013431 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Van B Ly Llc | 7416021639 | 2 |
News Archive
There is a close relationship between infection outbreaks on teeth and the presence of alopecia areata or localized alopecia, a type of hair loss which has an unknown origin.
Current guidelines do not distinguish between aspirin and more potent blood thinners for protecting against blood clots in patients who undergo major orthopedic operations, leaving the decision up to individual clinicians.
BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases.
Osiris Therapeutics, Inc. today announced that Health Canada has requested additional information in support of the Company's application for approval of Prochymal, a stem cell therapy, for the treatment of graft vs. host disease (GvHD).
› Verified 8 days ago
| Provider Name | Van B Ly Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1154585024 PECOS PAC ID: 7416021639 Enrollment ID: O20080812000241 |
News Archive
There is a close relationship between infection outbreaks on teeth and the presence of alopecia areata or localized alopecia, a type of hair loss which has an unknown origin.
Current guidelines do not distinguish between aspirin and more potent blood thinners for protecting against blood clots in patients who undergo major orthopedic operations, leaving the decision up to individual clinicians.
BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases.
Osiris Therapeutics, Inc. today announced that Health Canada has requested additional information in support of the Company's application for approval of Prochymal, a stem cell therapy, for the treatment of graft vs. host disease (GvHD).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Van B Ly, OD 319 7th Ave Se, Suite #101, Olympia, WA 98501-1325 Ph: (360) 357-2544 | Dr Van B Ly, OD 319 7th Ave Se, Suite #101, Olympia, WA 98501-1325 Ph: (360) 357-2544 |
News Archive
There is a close relationship between infection outbreaks on teeth and the presence of alopecia areata or localized alopecia, a type of hair loss which has an unknown origin.
Current guidelines do not distinguish between aspirin and more potent blood thinners for protecting against blood clots in patients who undergo major orthopedic operations, leaving the decision up to individual clinicians.
BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases.
Osiris Therapeutics, Inc. today announced that Health Canada has requested additional information in support of the Company's application for approval of Prochymal, a stem cell therapy, for the treatment of graft vs. host disease (GvHD).
› Verified 8 days ago
Dr. Jay Woodworth Nelson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 625 Black Lake Blvd Sw, Olympia, WA 98502 Phone: 360-943-2334 Fax: 360-943-2879 | |
Dr. James H. Grimes, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1405 Harrison Ave Nw, Ste. 101, Olympia, WA 98502 Phone: 360-357-5548 Fax: 360-786-9797 | |
Dr. Kimberly A Carr-yeates, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1510 Cooper Point Rd Sw, Ste 110, Olympia, WA 98502 Phone: 360-489-0493 Fax: 360-943-9424 | |
Dr. Joseph Beaushaw, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 625 Black Lake Blvd Sw, Olympia, WA 98502 Phone: 360-943-2334 | |
Brian W Sullivan, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 215 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-456-4800 Fax: 360-456-4812 | |
Olympia Eye Clinic Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 215 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-456-4800 Fax: 360-456-4812 | |
Kim L Hoover, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7650 |